| Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors EE Mulvihill, DJ Drucker Endocrine reviews 35 (6), 992-1019, 2014 | 638 | 2014 |
| GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE−/− Mice N Panjwani, EE Mulvihill, C Longuet, B Yusta, JE Campbell, TJ Brown, ... Endocrinology 154 (1), 127-139, 2013 | 378 | 2013 |
| Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor–null mice with diet-induced insulin resistance EE Mulvihill, EM Allister, BG Sutherland, DE Telford, CG Sawyez, ... Diabetes 58 (10), 2198-2210, 2009 | 358 | 2009 |
| Citrus flavonoids and lipid metabolism JM Assini, EE Mulvihill, MW Huff Current opinion in lipidology 24 (1), 34-40, 2013 | 318 | 2013 |
| Antiatherogenic properties of flavonoids: implications for cardiovascular health EE Mulvihill, MW Huff Canadian Journal of Cardiology 26, 17A-21A, 2010 | 259 | 2010 |
| Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis EE Mulvihill, MW Huff Annual Review of Nutrition 36 (1), 2016 | 243 | 2016 |
| GLP-1 receptor expression within the human heart LL Baggio, B Yusta, EE Mulvihill, X Cao, CJ Streutker, J Butany, ... Endocrinology 159 (4), 1570-1584, 2018 | 240 | 2018 |
| Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance EE Mulvihill, JM Assini, JK Lee, EM Allister, BG Sutherland, JB Koppes, ... Diabetes 60 (5), 1446-1457, 2011 | 213 | 2011 |
| Naringenin Decreases Progression of Atherosclerosis by Improving Dyslipidemia in High-Fat–Fed Low-Density Lipoprotein Receptor–Null Mice EE Mulvihill, JM Assini, BG Sutherland, AS DiMattia, M Khami, JB Koppes, ... Arteriosclerosis, thrombosis, and vascular biology 30 (4), 742-748, 2010 | 193 | 2010 |
| Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr−/− mice JM Assini, EE Mulvihill, BG Sutherland, DE Telford, CG Sawyez, ... Journal of lipid research 54 (3), 711-724, 2013 | 167 | 2013 |
| TCF1 links GIPR signaling to the control of beta cell function and survival JE Campbell, JR Ussher, EE Mulvihill, J Kolic, LL Baggio, X Cao, Y Liu, ... Nature medicine 22 (1), 84-90, 2016 | 141 | 2016 |
| Inactivation of the cardiomyocyte Glucagon-Like Peptide-1 Receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection JR Ussher, LL Baggio, JE Campbell, EE Mulvihill, M Kim, MG Kabir, ... Molecular Metabolism, 0 | 138 | |
| Circulating levels of soluble dipeptidyl peptidase-4 are dissociated from inflammation and induced by enzymatic DPP4 inhibition EM Varin, EE Mulvihill, JL Beaudry, G Pujadas, S Fuchs, JF Tanti, S Fazio, ... Cell metabolism 29 (2), 320-334. e5, 2019 | 125 | 2019 |
| Naringenin Prevents Obesity, Hepatic Steatosis, and Glucose Intolerance in Male Mice Independent of Fibroblast Growth Factor 21 JM Assini, EE Mulvihill, AC Burke, BG Sutherland, DE Telford, ... Endocrinology 156 (6), 2087-2102, 2015 | 113 | 2015 |
| Cellular sites and mechanisms linking reduction of dipeptidyl peptidase-4 activity to control of incretin hormone action and glucose homeostasis EE Mulvihill, EM Varin, B Gladanac, JE Campbell, JR Ussher, LL Baggio, ... Cell metabolism 25 (1), 152-165, 2017 | 103 | 2017 |
| The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice LL Baggio, JR Ussher, BA McLean, X Cao, MG Kabir, EE Mulvihill, ... Molecular metabolism 6 (11), 1339-1349, 2017 | 98 | 2017 |
| Distinct Neural Sites of GLP-1R Expression Mediate Physiological versus Pharmacological Control of Incretin Action EM Varin, EE Mulvihill, LL Baggio, JA Koehler, X Cao, RJ Seeley, ... Cell reports 27 (11), 3371-3384. e3, 2019 | 96 | 2019 |
| Inhibition of dipeptidyl peptidase-4 impairs ventricular function and promotes cardiac fibrosis in high fat–fed diabetic mice EE Mulvihill, EM Varin, JR Ussher, JE Campbell, KWA Bang, T Abdullah, ... Diabetes 65 (3), 742-754, 2016 | 89 | 2016 |
| Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism NA Trzaskalski, E Fadzeyeva, EE Mulvihill Clinical Medicine Insights: Endocrinology and Diabetes 13, 1179551420912972, 2020 | 84 | 2020 |
| Inactivation of the glucose-dependent insulinotropic polypeptide receptor improves outcomes following experimental myocardial infarction JR Ussher, JE Campbell, EE Mulvihill, LL Baggio, HE Bates, BA McLean, ... Cell metabolism 27 (2), 450-460. e6, 2018 | 80 | 2018 |
